Your browser doesn't support javascript.
loading
Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-ß1 Epithelial Mesenchymal Transition.
Mazza, Giuseppe; Telese, Andrea; Al-Akkad, Walid; Frenguelli, Luca; Levi, Ana; Marrali, Martina; Longato, Lisa; Thanapirom, Kessarin; Vilia, Maria Giovanna; Lombardi, Benedetta; Crowley, Claire; Crawford, Mark; Karsdal, Morten A; Leeming, Diana J; Marrone, Giusi; Bottcher, Katrin; Robinson, Benjamin; Del Rio Hernandez, Armando; Tamburrino, Domenico; Spoletini, Gabriele; Malago, Massimo; Hall, Andrew R; Godovac-Zimmermann, Jasminka; Luong, Tu Vinh; De Coppi, Paolo; Pinzani, Massimo; Rombouts, Krista.
Afiliação
  • Mazza G; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Telese A; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Al-Akkad W; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Frenguelli L; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Levi A; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Marrali M; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Longato L; Engitix Ltd., London NW3 2PF, UK.
  • Thanapirom K; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Vilia MG; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Lombardi B; Proteomics and Molecular Cell Dynamics, Centre for Nephrology, School of Life and Medical Sciences, University College London, London NW3 2PF, UK.
  • Crowley C; Stem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme, UCL Institute for Child Health, Great Ormond Street Hospital, University College London, London WC1N 3JH, UK.
  • Crawford M; Proteomics and Molecular Cell Dynamics, Centre for Nephrology, School of Life and Medical Sciences, University College London, London NW3 2PF, UK.
  • Karsdal MA; Nordic Bioscience, Biomarkers & Research, Herlev Hovedgade 205-207, 2730 Herlev, Denmark.
  • Leeming DJ; Nordic Bioscience, Biomarkers & Research, Herlev Hovedgade 205-207, 2730 Herlev, Denmark.
  • Marrone G; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Bottcher K; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Robinson B; Department of Bioengineering, Cellular and Molecular Biomechanics. Imperial College, London SW7 2AZ, UK.
  • Del Rio Hernandez A; Department of Bioengineering, Cellular and Molecular Biomechanics. Imperial College, London SW7 2AZ, UK.
  • Tamburrino D; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Spoletini G; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Malago M; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Hall AR; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Godovac-Zimmermann J; Sheila Sherlock Liver Centre, Royal Free London NHS foundation trust, NW3 2PF London, UK.
  • Luong TV; Proteomics and Molecular Cell Dynamics, Centre for Nephrology, School of Life and Medical Sciences, University College London, London NW3 2PF, UK.
  • De Coppi P; Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London (UCL), London NW3 2PF, UK.
  • Pinzani M; Sheila Sherlock Liver Centre, Royal Free London NHS foundation trust, NW3 2PF London, UK.
  • Rombouts K; Stem Cells and Regenerative Medicine Section, Developmental Biology and Cancer Programme, UCL Institute for Child Health, Great Ormond Street Hospital, University College London, London WC1N 3JH, UK.
Cells ; 9(1)2019 12 28.
Article em En | MEDLINE | ID: mdl-31905709
ABSTRACT
An altered liver microenvironment characterized by a dysregulated extracellular matrix (ECM) supports the development and progression of hepatocellular carcinoma (HCC). The development of experimental platforms able to reproduce these physio-pathological conditions is essential in order to identify and validate new therapeutic targets for HCC. The aim of this work was to validate a new in vitro model based on engineering three-dimensional (3D) healthy and cirrhotic human liver scaffolds with HCC cells recreating the micro-environmental features favoring HCC. Healthy and cirrhotic human livers ECM scaffolds were developed using a high shear stress oscillation-decellularization procedure. The scaffolds bio-physical/bio-chemical properties were analyzed by qualitative and quantitative approaches. Cirrhotic 3D scaffolds were characterized by biomechanical properties and microarchitecture typical of the native cirrhotic tissue. Proteomic analysis was employed on decellularized 3D scaffolds and showed specific enriched proteins in cirrhotic ECM in comparison to healthy ECM proteins. Cell repopulation of cirrhotic scaffolds highlighted a unique up-regulation in genes related to epithelial to mesenchymal transition (EMT) and TGFß signaling. This was also supported by the presence and release of higher concentration of endogenous TGFß1 in cirrhotic scaffolds in comparison to healthy scaffolds. Fibronectin secretion was significantly upregulated in cells grown in cirrhotic scaffolds in comparison to cells engrafted in healthy scaffolds. TGFß1 induced the phosphorylation of canonical proteins Smad2/3, which was ECM scaffold-dependent. Important, TGFß1-induced phosphorylation of Smad2/3 was significantly reduced and ECM scaffold-independent when pre/simultaneously treated with the TGFß-R1 kinase inhibitor Galunisertib. In conclusion, the inherent features of cirrhotic human liver ECM micro-environment were dissected and characterized for the first time as key pro-carcinogenic components in HCC development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Smad / Matriz Extracelular / Fator de Crescimento Transformador beta1 / Alicerces Teciduais / Transição Epitelial-Mesenquimal / Cirrose Hepática Tipo de estudo: Etiology_studies / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Smad / Matriz Extracelular / Fator de Crescimento Transformador beta1 / Alicerces Teciduais / Transição Epitelial-Mesenquimal / Cirrose Hepática Tipo de estudo: Etiology_studies / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
...